Home › Kanser ng Endometrium › North Carolina › Durham

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Durham, NC

16 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Durham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Nagre-recruitPhase 3

Duke University Medical Center, Durham
UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Okt 5, 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2

Duke University Medical Center, Durham

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

A Study of PHST001 in Advanced Solid Tumors

Nagre-recruitPhase 1

Duke Cancer Institute, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06840886

Tirzepatide in Obesity-Driven Endometrial Cancer

Nagre-recruitMaagang Phase 1

Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT07065552

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2

Duke University, Durham

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Nagre-recruitPhase 2

Duke University Medical Center, Durham

Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601

DESTINY-PANTUMOUR04

Nagre-recruitObservasyonal na pag-aaral

Research Site, Durham

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Nagre-recruitPhase 2

Duke University Medical Center, Durham
UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT05640999

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Nagre-recruitPhase 3

Duke Cancer Institute ( Site 6049), Durham

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06952504

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Nagre-recruitObservasyonal na pag-aaral

UNC- Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Nagre-recruitPhase 3

Duke Cancer Institute, Durham

Edad 18 pataas · Kababaihan · Na-update Set 9, 2026 · NCT07166094

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Nagre-recruitPhase 1

Duke Cancer Institute, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06515613

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Duke University, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Nagre-recruitPhase 1

Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Ene 29, 2026 · NCT05542407

Multimedia Aid for Genetic Testing in Gynecologic Oncology

Nagre-recruit

Univeristy of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Nob 12, 2025 · NCT07084168

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod

Iba pang pag-aaral sa Durham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.